Consequently, the performance of serum AFP is heavily influenced by ALT levels, and AFP surveillance is less useful in patients with ALT > 40 UI/L (AUC of AFP for HCC 0.91 with ALT < 40 UI/L vs. 0.76 with ALT > 40 UI/L) [85]. The gene discussed is AFP; the disease is hepatocellular carcinoma.